LT indications were: post-viral C cirrhosis 33.7%, ethanol cirrhosis 28.7%, cryptogenic cirrhosis 20.8%, post-viral B cirrhosis 6.9%, primary biliary cirrhosis 3.9%, and others 5.9%.
Las indicaciones de TH fueron: cirrosis posviral C 33,7%, cirrosis etanólica 28,7%, cirrosis criptogénica 20,8%, cirrosis posviral B 6,9%, cirrosis biliar primaria 3,9% y otras 5,9%.
As indicações de TH foram: cirrose pós-viral C 33,7%, cirrose etanólica 28,7%, cirrose criptogênica 20,8%, cirrose pós-viral B 6,9%, cirrose biliar primária 3,9% e outras 5,9%.